GZMB and neoplasm: Through further analysis by the immunofluorescence of CD3+ T cells along with the apoptosis marker TUNEL, we found that tumor apoptosis was elevated after sirolimus treatment (Figure 6C), providing additional supporting evidence for treatment-related change in the tumor microenvironment which the number of GZMB-producing cytotoxic T cells was increased.